Matthew Gline

CIK 1750094 · CEO · last filed 2026-10-02

Matthew Gline is a CEO who has filed 73 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider had shares withheld for taxes covering $2.8M of ROIV on Oct 2, 2026. Across all open-market trades the lifetime net is −$71.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $596.2M across reported positions. 73 SEC filings were submitted jointly with Roivant Sciences Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$596.19M

Companies

Total Filings

Lifetime Open-Market Net

-$71.73M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

50 BROADWAY
7TH FLOOR
LONDON SW1H 0DB

Related Filers

Roivant Sciences Ltd. — 73 joint filings, latest 2026-07-02

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ROIV	CEO	16,583,774	$35.95	$596.19M	-$69.51M	31	2026-10-02
Roivant Sciences Ltd. (ROIVW) Delisted	CEO	1,051,732	$2.75	$2.89M	-$2.22M	26	2023-08-29

Recent Filings

73 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-10-02	ROIV	Tax (F)	−76,171	-$2.79M	EDGAR
2026-07-02	ROIV	Tax (F)	−76,171	-$2.70M	EDGAR
2026-04-20	ROIV	Sell (S)	−289,774	-$8.45M	EDGAR
2026-04-16	ROIV	Notice (144/A)	−289,774	-$8.45M	EDGAR
2026-04-16	ROIV	Notice (144)	−289,774	-$8.45M	EDGAR
2026-04-01	ROIV	Mixed	−261,191	-$9.86M	EDGAR
2025-12-17	ROIV	Mixed	—	-$36.85M	EDGAR
2025-12-15	ROIV	Notice (144/A)	−1,740,000	-$37.72M	EDGAR
2025-12-15	ROIV	Notice (144)	−1,740,000	-$37.72M	EDGAR
2025-09-18	ROIV	Buy (P)	+3,315	$50.0K	EDGAR

Showing 1–10 of 73

Page 1 of 8 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.